ArticleOncotarget2017

Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors.

Kieuhoa T Vo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.